05.15.2017 - By ReachMD
Host: John J. Russell, MD
Guest: Wendy S. Lane, MD
In this interview, Dr. Lane will review the clinical evidence supporting combinations of GLP-1 receptor agonists with basal insulin for the treatment of type 2 diabetes.